This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers therapeutic developments around ageing and age-related diseases. Senolytics and senomorphics targeting multiple pathways have been captured in this issue. Few innovations in companion diagnostics which can be used to drive precision medicine efforts have also been covered.
• In addition, innovations in digitization and use of AI in healthcare, such as drug discovery, diagnostics and biomanufacturing have been discussed.
• Development of antibodies and ADCs (antibody drug conjugates) are also highlighted.
• The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled market intelligence, technology insights, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.